CLDI

Healthcare

Calidi Biotherapeutics, Inc.

$0.32-0.02 (-4.72%)

Prev Close

$0.33

Open

$0.33

High

$0.33

Low

$0.31

Volume

201.3K

Market Cap

$2.6M

P/E

—

Div Yield

—

Over the past 12 months, insider activity at Calidi Biotherapeutics, Inc. (CLDI) has been dominated by buying, with 4 insider purchases totaling $455.0K and 1 insider sale totaling $1.2K. The most recent insider transaction was by Camaisa Allan (Director), who sold $1.2K worth of shares on Dec 12, 2025. Calidi Biotherapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.6M.

Buys (12M)

$455.0K

Sells (12M)

$1.2K

Net Activity

Net Buyer

$453.8K

Active Insiders

last 12 mo

CLDI Price Chart

CLDI Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Dec 12, 2025↗	Camaisa Allan	Director	Sell	850	$1.46	$1.2K	0
Aug 25, 2025↗	Poma Eric E	Chief Executive Officer	Buy	25,000	$2.00	$50.0K	0
Aug 21, 2025↗	Jackson Andrew C.	Chief Financial Officer	Buy	2,500	$2.00	$5.0K	0
Aug 21, 2025↗	Leftwich Scott	Director	Buy	125,000	$2.00	$250.0K	0
Aug 21, 2025↗	Schoeneck James A	Director	Buy	75,000	$2.00	$150.0K	0
Dec 18, 2024↗	Camaisa Allan	CEO and Chairman of the Board	Sell	10,000	$1.62	$16.2K	66,712
Oct 21, 2022↗	Polar Asset Management Partners Inc.	10% Owner	Sell	36,200	$9.90	$358.4K	412,800
Sep 14, 2022↗	First Light Acquisition Group, LLC	Chief Executive Officer	Sell	850,000	$0.58	$490.0K	2,874,680

CLDI Insider Buying Activity

The following table shows recent insider purchases of Calidi Biotherapeutics, Inc. (CLDI) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Aug 25, 2025↗	Poma Eric E	Chief Executive Officer	Buy	25,000	$2.00	$50.0K
Aug 21, 2025↗	Jackson Andrew C.	Chief Financial Officer	Buy	2,500	$2.00	$5.0K
Aug 21, 2025↗	Leftwich Scott	Director	Buy	125,000	$2.00	$250.0K
Aug 21, 2025↗	Schoeneck James A	Director	Buy	75,000	$2.00	$150.0K

CLDI Insider Selling Activity

The following table shows recent insider sales of Calidi Biotherapeutics, Inc. (CLDI) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Dec 12, 2025↗	Camaisa Allan	Director	Sell	850	$1.46	$1.2K	0
Dec 18, 2024↗	Camaisa Allan	CEO and Chairman of the Board	Sell	10,000	$1.62	$16.2K	66,712
Oct 21, 2022↗	Polar Asset Management Partners Inc.	10% Owner	Sell	36,200	$9.90	$358.4K	412,800
Sep 14, 2022↗	First Light Acquisition Group, LLC	Chief Executive Officer	Sell	850,000	$0.58	$490.0K	2,874,680